Is Qdel a good buy?
Quidel has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Will Qdel go up?
Based on our forecasts, a long-term increase is expected, the "QDEL" stock price prognosis for 2027-05-26 is 238.535 USD. With a 5-year investment, the revenue is expected to be around +130.62%. Your current $100 investment may be up to $230.62 in 2027.
Is Quidel a publicly traded company?
Quidel Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide....Quidel.TypePublicTraded asNasdaq: QDEL S&P 400 componentIndustryPharmaceutical IndustryFounded1979FoundersDr. David H. Katz, M.D.6 more rows
What is the target price for Qdel?
Stock Price Target QDELHigh$219.00Median$136.00Low$125.00Average$160.00Current Price$92.74
Is Quidel a biotech company?
Quidel Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system.
Where is Quidel manufactured?
Quidel's QuickVue® and Sofia® SARS Antigen test kits are made in the greater San Diego metropolitan area of California.
What does Quidel Corporation do?
Quidel Corporation (Nasdaq: QDEL) is a California-based leading manufacturer of diagnostic healthcare solutions serving to enhance the health and well-being of people around the globe.